Home › Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells
 

Keywords :   


Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells

2013-06-05 07:10:25| drugdiscoveryonline News Articles

Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a new IND-Enabling study in which Adva-27a, the Company's flagship oncology drug candidate for breast cancer was found to be effective at killing Pancreatic Cancer Cells in vitro

Tags: drug cells cancer candidate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.09Tropical Storm John Graphics
25.09Tropical Storm John Public Advisory Number 11A
25.09Summary for Tropical Storm John (EP5/EP102024)
25.09Hurricane Helene Public Advisory Number 9A
25.09Summary for Hurricane Helene (AT4/AL092024)
25.09Atlantic Tropical Weather Outlook
25.09Eastern North Pacific Tropical Weather Outlook
25.09Fall calving considerations
More »